Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20015001HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063337HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063338HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063339HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063340HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20015000HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020581HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20034037HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20034033HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20034034HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TCGA Plot Options
Drug Information
GeneCD274
DrugBank IDDB09035
Drug NameNivolumab
Target IDBE0003441
UniProt IDQ9NZQ7
Regulation Typeinhibitor
PubMed IDs33807678
CitationsKyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A: Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. J Fungi (Basel). 2021 Mar 5;7(3). pii: jof7030186. doi: 10.3390/jof7030186.
GroupsApproved
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBLCHEMBL2108738